[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350189-105":59,"doc-detail-350189-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","ephrin-a4-ligand-promotes-gastric-cancer-cell-epithelial-mesenchymal-transition-via-the-pi3kakt-signaling-pathway","Ephrin-A4 ligand promotes gastric cancer cell epithelial-mesenchymal transition via the PI3K/AKT signaling pathway","","Background: EFNA4 (ephrin-A4) participates in the progression of multiple malignant neoplasms, but its functional role in gastric cancer remains insufficiently defined. Methods and Results: Bioinformatics and clinical analysis of 93 patients showed elevated EFNA4 in gastric tumors, correlating with tumor size, AJCC stage, histological grade, and Ki-67; higher EFNA4 predicted worse overall survival. In AGS cells, EFNA4 silencing reduced proliferation, invasion, and migration and inhibited EMT by modulating PI3K/AKT signaling. Treatment with the PI3K activator 740Y-P restored PI3K/AKT protein expression and reversed the anti-cancer effects. Conclusions: EFNA4 may act upstream of PI3K/AKT and promote EMT during gastric cancer progression.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ephrin-a4-ligand-promotes-gastric-cancer-cell-epithelial-mesenchymal-transition-via-the-pi3kakt-signaling-pathway/350189/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ephrin-a4-ligand-promotes-gastric-cancer-cell-epithelial-mesenchymal-transition-via-the-pi3kakt-signaling-pathway/350189.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"How does activating PI3K affect the results of EFNA4 knockdown?","Question",{"text":112,"@type":113},"The PI3K activator 740Y-P increased PI3K/AKT-related protein expression and reversed the inhibition of malignant behaviors caused by EFNA4 knockdown.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},350189,1790941367,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":137,"preview_page_count":19,"preview_urls":138},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Huang et al. Discover Oncology (2026) 17:659 [https://doi.org/10.1007/s12672-026-04868-7](https://doi.org/10.1007/s12672-026-04868-7)  \nDiscover Oncology  \nRESEARCH Open Access  \nEphrin-A4 ligand promotes gastric cancer cell epithelial-mesenchymal transition via the PI3K/ AKT signaling pathway  \nCheng Huang1,2†, Min Li2†, Juan-Juan Hong2, Shuang-Yang Mo3, Jun-Jie Kuang2,4*, Jing-Zhang Li2* and Jie-An Huang1*  \n†Cheng Huang and Min Li have contributed equally to this work.  \n*Correspondence:  \nJun-Jie Kuang [kuangjj3@mail2.sysu.edu.cn](kuangjj3@mail2.sysu.edu.cn)[ ](kuangjj3@mail2.sysu.edu.cn)Jing-Zhang Li  \n[lzryljz@163.com](lzryljz@163.com)  \nJie-An Huang  \n[hjagxmu@163.com](hjagxmu@163.com)[ ](hjagxmu@163.com)1Department of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, Guangxi, China 2Department of Oncology, Liuzhou People’s Hospital, The Affiliated Liuzhou People’s Hospital of Guangxi Medical University, Liuzhou 545006, Guangxi, China 3Department of Gastroenterology, Liuzhou People’s Hospital, The Affiliated Liuzhou People’s Hospital of Guangxi Medical University, Liuzhou 545006, Guangxi, China 4Department of Oncology, Luzhai People’s Hospital, LuzhaiLiuzhou, China  \nAbstract  \nBackground Ephrin-A4 (EFNA4), a member of the ephrin ligand family, is known to be involved in the progression of various malignant neoplasms. Nonetheless, its specific functional implications in gastric cancer (GC) remain inadequately characterized. Therefore, this study aims to elucidate the underlying mechanisms by which EFNA4 influences GC.  \nMethods and Results Initially, bioinformatics analyses revealed significantly elevated EFNA4 expression levels in gastric cancer tissues when compared with normal counterparts. Additionally, clinical assessments from a cohort of 93 GC patients demonstrated a correlation between EFNA4 expression and factors such as tumor size, AJCC stage, histological grade, and Ki-67 staining score. Furthermore, high levels of EFNA4 expression were associated with decreased overall survival, underscoring its potential as a prognostic biomarker. In vitro functional assays conducted in the human gastric cancer cell line AGS demonstrated that EFNA4 silencing markedly suppressed GC cell proliferation, invasion, and migration. Moreover, knockdown of EFNA4 impeded the process of epithelial-mesenchymal transition (EMT) through the modulation of the PI3K/AKT signaling pathway. Treatment with 740Y-P, a PI3K activator, was observed to enhance the expression of PI3K/AKT-related proteins and reverse the inhibition of malignant behavior in gastric cancer cells caused by EFNA4 knockdown.  \nConclusions Our findings suggest that EFNA4 may act as an upstream regulator of the PI3K/AKT signaling pathway and could play a role in promoting EMT during the progression of gastric cancer.  \nKeywords EFNA4, Gastric cancer, Epithelial-mesenchymal transition, PI3K/AKT  \n1 Introduction  \nGastric cancer (GC) ranks as the fifth most prevalent malignancy and accounts for the fifth highest cancer-related mortality globally [1]. In China, recent statistics indicate that the crude incidence rate of GC reached 341.75 per 100,000 individuals in 2022, with a corresponding crude mortality rate of 18.44 per 100,000 individuals [2]. Patients  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwi","cbCaibBKPMF6qch0","https://ap.wps.com/l/cbCaibBKPMF6qch0","pdf",2659535,18,"English","# Abstract\n# Introduction\n# Methods and Results\n# Conclusions","[{\"question\":\"How does activating PI3K affect the results of EFNA4 knockdown?\",\"answer\":\"The PI3K activator 740Y-P increased PI3K/AKT-related protein expression and reversed the inhibition of malignant behaviors caused by EFNA4 knockdown.\"}]","Ephrin-A4 ligand promotes gastric cancer cell epithelial-mesenchymal transition via the PI3K/AKT signaling pathway | PDF",1790087618,45,[139,143,147,151],{"page_no":8,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cab3c9876a43c754d9677b8ba8c4d1a7.webp",983,1310,{"page_no":14,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/426c089cd50c0577ae6e57519aed4289.webp",982,1309,{"page_no":81,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ec4a386159a5e12608ef70c5194f176.webp",981,1308,{"page_no":19,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/755dfe246cacbd4d4e3517ed73492a9f.webp",980,1306]